Number of the records: 1
Trendy vo farmakoekonomike v kardiológii
SYS 0103161 LBL 00000naa--2200000-a-4500 005 20250607152038.6 008 141031c2014----xo-----e------------slo-- 040 $a BA006 $b slo 041 0-
$a slo $a eng 044 $a xo $c SK 100 1-
$7 sllk_us_auth*0031626 $a Hoffmannová, Karolina $u AstraZeneca AB, o.z., Bratislava $4 aut 245 10
$a Trendy vo farmakoekonomike v kardiológii : $b podľa výstupov 16. kongresu ISPOR v Dubline / $c Karolina Hoffmannová 300 $b ilustr., tab. 505 10
$t Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis $r Egter et al. -- $t What factors predict the decision to treat acute coronary syndrome invasively? Evidence from clinical practice $r Fakhouri et al. -- $t Patient-level costs of cardiovascular events and procedures: how robust is the evidence? $r Nicholson et al. -- $t Application of new french guidelines for economic evaluations: a cost-effectiveness analysis of apixaban in patients with non-valvular atrial fibrillation in France $r Durand Zaleski 650 12
$7 sllk_us_auth*d017850 $a farmakoekonomika $x trendy $2 mesh 650 12
$7 sllk_us_auth*d002318 $a choroby kardiovaskulárne $x ekonomika $2 mesh 650 22
$7 sllk_us_auth*d017202 $a choroba srdca, ischemická $x ekonomika $2 mesh 650 22
$7 sllk_us_auth*d019468 $a manažment choroby $2 mesh 650 22
$7 sllk_us_auth*d000925 $a antikoagulanciá $x ekonomika $2 mesh 653 2-
$a postery 711 2-
$7 sllk_us_auth*0033579 $a Farmakoekonomika na Slovensku $e Vedecká konferencia SSFE a Kancelárie WHO s medzinárodnou účasťou $n (27. : $d 2014 : $c Bratislava, Slovensko) 773 0-
$7 nnas $w sllk_us_cat*0101364 $t Farmakoekonomika a lieková politika $x 1336-7021 $d Nové Mesto nad Váhom : TISING, 2014 $g Roč. 10, č. 2 (2014), s. 41-42
Number of the records: 1